One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design
doi : 10.1002/art.43053
Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology
doi : 10.1002/art.43050
Target Trial Emulations of Sodium-Glucose Cotransporter 2 Inhibitors in Systemic Lupus Erythematosus
doi : 10.1002/art.43130
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib
doi : 10.1002/art.43042
Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real-World Early Rheumatoid Arthritis Cohort
doi : 10.1002/art.43049
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-Based Target Trial Emulation
doi : 10.1002/art.43037
FoxO1 Deficiency in Monocytic Myeloid-Derived Suppressor Cells Exacerbates B Cell Dysfunction in Systemic Lupus Erythematosus
doi : 10.1002/art.43046
A Strong Dysregulated Myeloid Component in the Epigenetic Landscape of Systemic Sclerosis: An Integrated DNA Methylome and Transcriptome Analysis
doi : 10.1002/art.43044
Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis
doi : 10.1002/art.43051
Incidence and Genetic Risk of Juvenile Idiopathic Arthritis in Norway by Latitude
doi : 10.1002/art.43040
Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022
doi : 10.1002/art.43041
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project
doi : 10.1002/art.43038
Osteoarthritis: Magnetic resonance imaging definitions and disease progression: comment on the article by Chang et al
doi : 10.1002/art.43022
Incorrect about International Classification of Diseases coding for patients with systemic lupus erythematosus: comment on the article by Haukeland et al
doi : 10.1002/art.43025
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al
doi : 10.1002/art.43035
Clinical Images: A rare and misleading condition: isolated skeletal involvement of Erdheim–Chester disease
doi : 10.1002/art.43039
